BRPI0917462A2 - sistema automatizado para seleção e intermediação de células biológicas alógenas armazenadas para transplante, terapia e pesquisa - Google Patents

sistema automatizado para seleção e intermediação de células biológicas alógenas armazenadas para transplante, terapia e pesquisa

Info

Publication number
BRPI0917462A2
BRPI0917462A2 BRPI0917462A BRPI0917462A BRPI0917462A2 BR PI0917462 A2 BRPI0917462 A2 BR PI0917462A2 BR PI0917462 A BRPI0917462 A BR PI0917462A BR PI0917462 A BRPI0917462 A BR PI0917462A BR PI0917462 A2 BRPI0917462 A2 BR PI0917462A2
Authority
BR
Brazil
Prior art keywords
intermediation
transplantation
therapy
research
selection
Prior art date
Application number
BRPI0917462A
Other languages
English (en)
Inventor
Frank Keller
Thomas Klein
Original Assignee
Cytolon Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytolon Ag filed Critical Cytolon Ag
Publication of BRPI0917462A2 publication Critical patent/BRPI0917462A2/pt

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Biomedical Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0917462A 2008-08-14 2009-08-14 sistema automatizado para seleção e intermediação de células biológicas alógenas armazenadas para transplante, terapia e pesquisa BRPI0917462A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08075702 2008-08-14
US9007908P 2008-08-19 2008-08-19
PCT/EP2009/006053 WO2010018002A1 (de) 2008-08-14 2009-08-14 Automatisiertes system zur auswahl und vermittlung von gelagerten allogenen biologischen zellen für transplantation, therapie und forschung

Publications (1)

Publication Number Publication Date
BRPI0917462A2 true BRPI0917462A2 (pt) 2015-12-01

Family

ID=41207797

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917462A BRPI0917462A2 (pt) 2008-08-14 2009-08-14 sistema automatizado para seleção e intermediação de células biológicas alógenas armazenadas para transplante, terapia e pesquisa

Country Status (6)

Country Link
US (1) US8762071B2 (pt)
EP (1) EP2263183B1 (pt)
CN (1) CN102144233A (pt)
BR (1) BRPI0917462A2 (pt)
ES (1) ES2477883T3 (pt)
WO (1) WO2010018002A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2263183B1 (de) 2008-08-14 2014-04-30 Cytolon AG Automatisiertes system zur auswahl und vermittlung von gelagerten allogenen biologischen zellen für transplantation, therapie und forschung
WO2010089158A1 (de) * 2009-02-06 2010-08-12 Cytolon Ag Automatisiertes system zum vergleich individueller genom-, transkriptom-, proteom-, epigenom und metabolomdaten mit daten aus knochenmarkspender-registern und blut, nabelschnurblut und gewebebanken
WO2010089159A1 (de) 2009-02-06 2010-08-12 Cytolon Ag System für die bereitstellung individueller oder gepoolter auch anonymisierter patientendaten auf grundlage von molekularen genom-, transkriptom-, proteom-, epigenom oder metabolomdaten
US9251539B2 (en) * 2010-01-15 2016-02-02 Apollo Enterprise Solutions, Ltd. System and method for resolving transactions employing goal seeking attributes
CN103003820A (zh) * 2010-05-20 2013-03-27 赛特龙股份公司 鉴定和选择至少一个用于移植的脐带血单元
GB201415329D0 (en) 2014-07-21 2014-10-15 Ge Healthcare Bio Sciences Parallel cell processing method and facility
US11259520B2 (en) * 2016-08-04 2022-03-01 Fanuc Corporation Stem cell manufacturing system, stem cell information management system, cell transport apparatus, and stem cell frozen storage apparatus
CN108922605B (zh) * 2018-05-23 2020-10-27 上海楚腾信息技术有限公司 一种辅助生殖管理方法及其系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100883079B1 (ko) 1999-07-05 2009-02-10 노파르티스 아게 플랫폼, 플랫폼을 가지는 장치, 및 플랫폼을 사용하는 방법
US20030154108A1 (en) 2000-03-01 2003-08-14 Gambro, Inc. Extracorporeal blood processing information management system
US20020168639A1 (en) 2000-09-22 2002-11-14 Muraca Patrick J. Profile array substrates
GB2407193B (en) 2001-02-20 2005-06-29 Cytokinetics Inc Method and apparatus for automated cellular bioinformatics
US20020132343A1 (en) * 2001-03-19 2002-09-19 Clark Lum System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation
AU2002309152A1 (en) 2001-03-25 2002-10-08 Exiqon A/S Systems for analysis of biological materials
JP4562353B2 (ja) 2002-04-08 2010-10-13 株式会社リンフォテック Hla一致他人由来活性化リンパ球を含有してなる腫瘍・感染症および自己免疫疾患の予防・治療用製剤
AU2003265768A1 (en) 2002-08-28 2004-03-19 Applera Corporation Automated framework for the analysis of biological data
CN1961283A (zh) * 2004-03-26 2007-05-09 细胞基因公司 建立干细胞库的系统和方法
AU2006274029B2 (en) 2005-07-25 2011-07-14 Metanomics Gmbh Means and methods for analyzing a sample by means of chromatography-mass spectrometry
WO2007070280A2 (en) * 2005-12-02 2007-06-21 The General Hospital Corporation Use of deletion polymorphisms to predict, prevent, and manage histoincompatibility
EP2164953A4 (en) * 2007-06-18 2010-06-30 Childrens Hosp & Res Ct Oak METHOD OF ISOLATING STAIN AND PRECIPITATING CELLS FROM PLAZENTA
EP2263183B1 (de) 2008-08-14 2014-04-30 Cytolon AG Automatisiertes system zur auswahl und vermittlung von gelagerten allogenen biologischen zellen für transplantation, therapie und forschung
WO2010089159A1 (de) 2009-02-06 2010-08-12 Cytolon Ag System für die bereitstellung individueller oder gepoolter auch anonymisierter patientendaten auf grundlage von molekularen genom-, transkriptom-, proteom-, epigenom oder metabolomdaten
WO2010089158A1 (de) 2009-02-06 2010-08-12 Cytolon Ag Automatisiertes system zum vergleich individueller genom-, transkriptom-, proteom-, epigenom und metabolomdaten mit daten aus knochenmarkspender-registern und blut, nabelschnurblut und gewebebanken
EP2531975A2 (de) 2010-02-05 2012-12-12 Cytolon AG Automatisiertes system zur auswahl und vermittlung von gelagerten allogenen biologischen zellen für transplantation, therapie und forschung
CN103003820A (zh) 2010-05-20 2013-03-27 赛特龙股份公司 鉴定和选择至少一个用于移植的脐带血单元

Also Published As

Publication number Publication date
US20110257999A1 (en) 2011-10-20
US8762071B2 (en) 2014-06-24
EP2263183B1 (de) 2014-04-30
CN102144233A (zh) 2011-08-03
ES2477883T3 (es) 2014-07-18
WO2010018002A1 (de) 2010-02-18
EP2263183A1 (de) 2010-12-22

Similar Documents

Publication Publication Date Title
IL276146B1 (en) In vitro methods for increasing viability of immune-cells
IL285655B (en) A system for identifying bacteria in biological samples
BRPI0917462A2 (pt) sistema automatizado para seleção e intermediação de células biológicas alógenas armazenadas para transplante, terapia e pesquisa
IL275599A (en) A system for managing the identification of bacteria in biological samples
EP2714935A4 (en) SYSTEMS AND METHODS FOR GENETIC AND BIOLOGICAL ANALYSIS
EP2297182A4 (en) HIGHLY CHARGED PROTEINS USED FOR CELL PENETRATION
BRPI0918693A2 (pt) dispositivos para amostragem e métodos para concentração de microorganismos
BR112013015870A2 (pt) método para o tratamento de biomassa e sistema
EP2537016A4 (en) SYSTEM FOR THE REMOVAL OF BIOLOGICAL SAMPLES
BR112012006368A2 (pt) sistema de infusão de substâncias biológicas
CL2014000371A1 (es) Sistema de reactor biologico de membrana media suspendida
BR112012025667A2 (pt) sistema de distribuição de substância pura ou estéril
BRPI0806559A2 (pt) Sistema e método de monitor para semeadeira
BR112013010256A2 (pt) método e sistema de indicador biológico de esterilização
BR112014007789A2 (pt) sistemas e métodos para análise biológica
IL204756A0 (en) Biological specimen collection and transport system and methods of use
DE112011100442A5 (de) Automatisiertes system zur auswahl und vermittlung von gelagerten allogenen biologischen zellen für transplantation, therapie und forschung
BR112012009921A2 (pt) métodos para reprogramar células e usos do mesmos
BR112013005024A2 (pt) sistema e método para o tratamento biológico da matéria orgânica por meio de larvas de insetos
BRPI0917644A2 (pt) sistema transportador para agentes biológicos contendo compostos de organo-silício e usos do mesmo.
EP2361302A4 (en) ACTIVE MICROFLUID SYSTEM FOR IN VITRO CULTURES
BRPI1011127A2 (pt) métodos para o cultivo de células tronco e células progenitoras
ES2674239T8 (es) Medios para células madre pluripotentes carentes de alimentadores que contienen suero humano
ITMI20072439A1 (it) Gabbia di stabulazione per animali da laboratorio
BR112012032044A2 (pt) sistema para suporte de crescimento de algas com dióxido de carbono adsorvido

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2475 DE 12-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.